Showing results (81-90 of 319) with videos related to
Sort By:
Pageof 32
Journal of Cancer Research and Clinical Oncology|February 18, 2011
Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifenYong Wha Moon, Seho Park, Joo Hyuk Sohn, et al.Cancer Chemotherapy and Pharmacology|March 22, 2007
The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancerSang Joon Shin, Joong Bae Ahn, Hye Jin Choi, et al.Oncology|June 17, 2011
A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasisHyung Soon Park, Sun Young Rha, Hyo Song Kim, et al.Cancer Chemotherapy and Pharmacology|August 21, 2008
Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trialsHei-Cheul Jeung, Sun Young Rha, Sang Joon Shin, et al.Journal of Surgical Oncology|January 20, 2009
The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancerSung Jin Oh, Woo Jin Hyung, Chen Li, et al.International Journal of Molecular Medicine|August 8, 2002
Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatmentSun Young Rha, Hei Cheul Jeung, Jae Kyung Roh, et al.European Journal of Cancer (Oxford, England : 1990)|March 23, 2019
Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancerChan Kim, Hong Jae Chon, Joo Hoon Kim, et al.Genomics|September 23, 2008
In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancerJae-Joon Jung, Hei-Cheul Jeung, Hyun Cheol Chung, et al.American Journal of Clinical Oncology|September 5, 2009
A phase II study of a combined biweekly irinotecan and monthly cisplatin treatment for metastatic or recurrent gastric cancerChong Kun Im, Sun Young Rha, Hei-Cheul Jeung, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2018
A Multicenter Phase II Study of AMG 337 in Patients with MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other MET-Amplified Solid TumorsEric Van Cutsem, Boguslawa Karaszewska, Yoon-Koo Kang, et al.Pageof 32